Medical technology company, Fisher & Paykel Healthcare (FPH), continued its strong recent share price performance, finishing the quarter up 28.1%
Medical technology company, Fisher & Paykel Healthcare (FPH), continued its strong recent share price performance, finishing the quarter up 28.1%. Members of the team had extensive contact with the company during the quarter including a tour of the company's new manufacturing facility in Mexico and meetings with various members of the senior management team in the US, New Zealand and Australia. We expect both parts of the business (respiratory and acute care and obstructive sleep apnoea) to continue to grow at double digit rates over the medium term driven by market share gains and new product launches.
OC Funds Management (OC) is a boutique small cap specialist which was founded by its investment staff and non-executive directors. OC commenced operated in December 2000 with the launch of two long only small cap Australian equity funds, the OC...
No areas of expertise